Susquehanna Fundamental Investments LLC Purchases Shares of 13,689 Addus HomeCare Co. (NASDAQ:ADUS)

Susquehanna Fundamental Investments LLC bought a new position in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 13,689 shares of the company's stock, valued at approximately $1,716,000. Susquehanna Fundamental Investments LLC owned 0.08% of Addus HomeCare at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Natixis raised its holdings in shares of Addus HomeCare by 111.9% during the fourth quarter. Natixis now owns 250 shares of the company's stock worth $31,000 after purchasing an additional 132 shares during the period. Smartleaf Asset Management LLC increased its position in Addus HomeCare by 324.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 280 shares of the company's stock worth $35,000 after buying an additional 214 shares during the last quarter. Parkside Financial Bank & Trust increased its position in Addus HomeCare by 38.6% in the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock worth $67,000 after buying an additional 148 shares during the period. Meeder Asset Management Inc. bought a new stake in shares of Addus HomeCare in the 4th quarter worth approximately $77,000. Finally, Harvest Fund Management Co. Ltd acquired a new stake in shares of Addus HomeCare in the 4th quarter valued at $86,000. 95.35% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

ADUS has been the topic of several research reports. StockNews.com cut Addus HomeCare from a "buy" rating to a "hold" rating in a research note on Wednesday, February 26th. Oppenheimer lifted their target price on Addus HomeCare from $145.00 to $150.00 and gave the stock an "outperform" rating in a research note on Friday, January 24th. Macquarie reissued an "outperform" rating and set a $129.00 price objective on shares of Addus HomeCare in a report on Thursday, February 27th. JMP Securities reiterated a "market outperform" rating and issued a $150.00 price target on shares of Addus HomeCare in a research note on Tuesday, April 22nd. Finally, Stephens reissued an "overweight" rating and issued a $142.00 target price on shares of Addus HomeCare in a research report on Wednesday, March 12th. One equities research analyst has rated the stock with a hold rating, seven have assigned a buy rating and two have issued a strong buy rating to the company's stock. According to data from MarketBeat.com, Addus HomeCare currently has a consensus rating of "Buy" and a consensus price target of $139.00.

Addus HomeCare Price Performance

NASDAQ:ADUS traded up $4.55 during trading hours on Tuesday, reaching $108.92. 40,654 shares of the company were exchanged, compared to its average volume of 163,439. The firm has a market cap of $2.00 billion, a price-to-earnings ratio of 24.90, a PEG ratio of 1.41 and a beta of 0.85. The stock has a 50 day simple moving average of $97.64 and a 200 day simple moving average of $114.80. Addus HomeCare Co. has a 52-week low of $88.96 and a 52-week high of $136.72.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its quarterly earnings results on Monday, May 5th. The company reported $1.42 EPS for the quarter, topping the consensus estimate of $1.33 by $0.09. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business had revenue of $337.71 million during the quarter, compared to analyst estimates of $341.66 million. During the same quarter in the prior year, the firm earned $1.21 earnings per share. The company's quarterly revenue was up 20.3% on a year-over-year basis. On average, analysts predict that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.